We are live on ! Find out more
OM icon

Outset Medical
OM

162 hedge funds and large institutions have $957M invested in Outset Medical in 2023 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 59 increasing their positions, 41 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

132% more call options, than puts

Call options by funds: $723K | Put options by funds: $311K

68% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 19

44% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 41

7% more funds holding

Funds holding: 152 → 162 (+10)

0.36% more ownership

Funds ownership: 6.77% → 7.13% (+0.36%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

24% less capital invested

Capital invested by funds: $1.26B → $957M (-$305M)

Holders
162
Holders Change
+10
Holders Change %
+6.58%
% of All Funds
2.58%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
32
Increased
59
Reduced
41
Closed
19
Calls
$723K
Puts
$311K
Net Calls
+$412K
Net Calls Change
-$9.28M

Top Buyers

Rank Fund Capital Flow
1
Ameriprise
Ameriprise
Minnesota
+$18.6M
2
PVI
Pura Vida Investments
New York
+$11.4M
3
JP Morgan Chase
JP Morgan Chase
New York
+$10.3M
4
PHS
PFM Health Sciences
California
+$7.95M
5
Millennium Management
Millennium Management
New York
+$7.87M

Top Sellers

Rank Fund Capital Flow
1
Barclays
Barclays
United Kingdom
-$10.2M
2
PAMP
Polar Asset Management Partners
Ontario, Canada
-$7.33M
3
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$5.52M
4
WP
Woodline Partners
California
-$5.14M
5
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$4.81M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$8.05M +$56.2K +153 +0.5%
Citadel Advisors
27
Citadel Advisors
Florida
$6.89M +$4.39M +11,967 +92%
Allspring Global Investments
28
Allspring Global Investments
North Carolina
$6.67M +$1.79M +4,888 +25%
Charles Schwab
29
Charles Schwab
California
$6.6M -$12.5K -34 -0.1%
Fidelity International
30
Fidelity International
Bermuda
$6.58M +$52.5K +143 +0.6%
Millennium Management
31
Millennium Management
New York
$6.12M +$7.87M +21,436 +2,953%
PHS
32
PFM Health Sciences
California
$5.98M +$7.95M +21,665 New
N
33
Nuveen
North Carolina
$5.85M -$1.13M -3,084 -13%
Dimensional Fund Advisors
34
Dimensional Fund Advisors
Texas
$5.31M +$3.86M +10,503 +120%
Two Sigma Investments
35
Two Sigma Investments
New York
$5.17M +$6.87M +18,719 New
Federated Hermes
36
Federated Hermes
Pennsylvania
$4.86M +$6.12M +16,667 +1,786%
Ensign Peak Advisors
37
Ensign Peak Advisors
Utah
$4.63M -$3.92M -10,667 -39%
Voloridge Investment Management
38
Voloridge Investment Management
Florida
$4.34M +$2.63M +7,157 +84%
SAM
39
Sectoral Asset Management
Quebec, Canada
$3.39M +$1.08M +2,934 +31%
Deutsche Bank
40
Deutsche Bank
Germany
$3.33M +$155K +421 +4%
New York State Common Retirement Fund
41
New York State Common Retirement Fund
New York
$3.19M -$237K -646 -5%
Two Sigma Advisers
42
Two Sigma Advisers
New York
$2.87M +$3.82M +10,413 New
BFM
43
Boothbay Fund Management
New York
$2.8M +$3.73M +10,159 New
Renaissance Technologies
44
Renaissance Technologies
New York
$2.66M +$2.76M +7,507 +352%
Lazard Asset Management
45
Lazard Asset Management
New York
$2.66M +$3.45M +9,394 +4,015%
UBS AM
46
UBS AM
Illinois
$2.47M +$605K +1,648 +23%
Marshall Wace
47
Marshall Wace
United Kingdom
$2.23M +$2.97M +8,090 New
Goldman Sachs
48
Goldman Sachs
New York
$2.22M -$1.67M -4,556 -36%
State of Wisconsin Investment Board
49
State of Wisconsin Investment Board
Wisconsin
$2.2M +$134K +364 +5%
Amundi
50
Amundi
France
$2.04M -$13.2K -36 -0.5%
1
2
3 4 5

OM Hedge Fund Activity: Q1 2023 in Review

162 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q1 2023, worth a combined $957M — down 24% from $1.26B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new OM positions and 19 closed out — a net gain of 13 holders — while 59 added to existing stakes and 41 trimmed.

The largest buyer was Ameriprise, adding an estimated $18.6M. The largest seller was Barclays, cutting an estimated $10.2M.

  • 162 institutional investors held Outset Medical (OM) as of Q1 2023, up from 152 in Q4 2022.
  • Funds reported $957M of Outset Medical stock for Q1 2023, down 24% quarter-over-quarter.
  • 32 funds opened new Outset Medical positions in Q1 2023 and 19 closed out, a net change of +13 holders.
  • The largest Outset Medical buyer in Q1 2023 was Ameriprise, an estimated $18.6M added.
  • The largest Outset Medical seller in Q1 2023 was Barclays, an estimated $10.2M sold.

Based on aggregated 13F filings for Q1 2023.